Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Prostatic Neoplasms 29 Breast Neoplasms 28 Brain Neoplasms 21 Neoplasms 16 Glioma 10 Pancreatic Neoplasms 9 Head and Neck Neoplasms 8 Lymphoma 7 Uterine Cervical Neoplasms 6 Urinary Bladder Neoplasms 6 Rectal Neoplasms 6 Glioblastoma 6 Colonic Neoplasms 6 Carcinoma, Hepatocellular 6 Lymphoma, Non-Hodgkin 5 Lung Neoplasms 5 Astrocytoma 5 Triple Negative Breast Neoplasms 4 Squamous Cell Carcinoma of Head and Neck 4 Liver Neoplasms 4 Disease 4 Central Nervous System Neoplasms 4 Stomach Neoplasms 3 Spinal Cord Neoplasms 3 Sarcoma 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Esophageal Neoplasms 3 Carcinoma in Situ 3 Retinoblastoma 2 Pathologic Complete Response 2

Interventions

pembrolizumab 1 Vincristine 1 Vinblastine 1 Procarbazine 1 Prednisone 1 Methotrexate 1 Mercaptopurine 1 Magnetic Resonance Imaging 1 Etoposide 1 Drug Therapy 1 Doxorubicin 1 Dexamethasone 1 Daunorubicin 1 Data Collection 1 Cytarabine 1 Cyclophosphamide 1 Caspofungin 1 Blood Specimen Collection 1 BAY 1895344 1 Asparaginase 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Ataxia Telangiectasia × Magnetic Resonance Imaging × Clear all

NCT05252819 2024-02-07

Whole Body MRI for Cancer Surveillance in A-T

University of Nottingham

Ataxia Telangiectasia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡